Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33782081.
- Also identified by DOI 10.1136/thoraxjnl-2020-216526.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Non-pharmaceutical interventions (NPIs) have been widely implemented to mitigate the spread of COVID-19. We assessed the effect of NPIs on hospitalisations for pneumonia, influenza, COPD and asthma. This retrospective, ecological study compared the weekly incidence of hospitalisation for four respiratory conditions before (January 2016-January 2020) and during (February-July 2020) the implementation of NPI against COVID-19. Hospitalisations for all four respiratory conditions decreased substantially during the intervention period. The cumulative incidence of admissions for COPD and asthma was 58% and 48% of the mean incidence during the 4 preceding years, respectively.
Medical subject headings
- Asthma
- COVID-19
- Influenza, Human
- Patient Admission
- Pulmonary Disease, Chronic Obstructive